Search Results - Solbach, C.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-n... by Meyer-Wilmes, Philipp (Author) , Huober, Jens (Author) , Untch, Michael (Author) , Blohmer, J. -U. (Author) , Janni, W. (Author) , Denkert, Carsten (Author) , Klare, P. (Author) , Link, T. (Author) , Rhiem, K. (Author) , Bayer, C. (Author) , Reinisch, M. (Author) , Bjelic-Radisic, V. (Author) , Zahm, Dirk-Michael (Author) , Hanusch, Claus Alexander (Author) , Solbach, C. (Author) , Heinrich, G. (Author) , Hartkopf, A. D. (Author) , Schneeweiss, Andreas (Author) , Fasching, Peter Andreas (Author) , Filmann, N. (Author) , Nekljudova, V. (Author) , Holtschmidt, J. (Author) , Stickeler, E. (Author) , Loibl, Sibylle (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response by Loibl, Sibylle (Author) , Schneeweiss, Andreas (Author) , Huober, J. (Author) , Braun, M. (Author) , Rey, J. (Author) , Blohmer, J. -U. (Author) , Furlanetto, J. (Author) , Zahm, D. -M. (Author) , Hanusch, C. (Author) , Thomalla, J. (Author) , Jackisch, C. (Author) , Staib, P. (Author) , Link, T. (Author) , Rhiem, K. (Author) , Solbach, C. (Author) , Fasching, P. A. (Author) , Nekljudova, V. (Author) , Denkert, C. (Author) , Untch, M. (Author) ,


    Get full text
    Article (Journal) Online Resource